Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension

NCT01642212 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT01642212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01642212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension
Lead sponsor
Shire
Phase
Phase 2
Overall status
Completed
Start date
July 23, 2012
Completion date
October 30, 2014
Enrollment
93 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

eosinophilic esophagitis (eoe)